logo

For the Inventor, By the Inventor

Nogent-Sur-Marne, France

Claude Dumont

USPTO Granted Patents = 32

Average Co-Inventor Count = 3.1

ph-index = 8

Forward Citations = 274(Granted Patents)


Location History:

  • Nogen-sur-Marne, FR (1979)
  • Nogent-sur-Marne, FR (1976 - 1984)

Company Filing History:

goldMedal32 out of 854 
 
Roussel Uclaf
 patents

Years Active: 1976-1984

Loading Chart...
32 patents (USPTO):Explore Patents
1. 4447438 - Dopaminergic stimulating piperidin-3-yl-indoles (1984-05-08),
2. 4435408 - Dopaminergic stimulating and antianoxic 4-substituted 2H-indole-2-ones (1984-03-06),
3. 4382942 - 3-(1,2,5,6-Tetrahydropyridin-3-yl)-phenols and their use in (1983-05-10),
4. 4335135 - 5 Amino-3,4,5,6 tetrahydro-1H-[-6-]cyclohept[c,d]indolols and a method (1982-06-15),
5. 4333939 - Tetrahydropyridinyl-indoles (1982-06-08),
6. 4332808 - Dopaminergically stimulating 4-substituted indoles (1982-06-01),
7. 4324790 - Antipsychotic tetrahydropyridinyl-indoles, compositions and method of use (1982-04-13),
8. 4318910 - Indolobenzoxazines (1982-03-09),
9. 4313944 - Cycloheptindoles, compositions and use (1982-02-02),
10. 4296126 - 3-Aryloxy-3-aryl-propaneamines and their method of use (1981-10-20),
11. 4278677 - Tetrahydropyridinyl indoles (1981-07-14),
12. 4259337 - Method for using m-trifluoromethylphenyl-piperidines (1981-03-31),
13. 4242355 - Novel 3-(aminoethyl)-phenols (1980-12-30),
14. 4232031 - Process for preparation of piperidyl-indoles (1980-11-04),
15. 4218375 - 4H-Thieno-[3,2-b][1]-benzazepines (1980-08-19),

Title: Claude Dumont: Innovator in Dopaminergic Compounds

Introduction

Claude Dumont, an accomplished inventor based in Nogent-sur-Marne, France, has made significant contributions to the field of pharmacology with his innovative research and development. With an impressive portfolio of 32 patents, his work primarily focuses on dopaminergic stimulating compounds that offer remarkable therapeutic properties.

Latest Patents

Dumont's latest patents showcase his expertise in novel compounds. One significant patent is for "Dopaminergic stimulating piperidin-3-yl-indoles." This patent emphasizes the unique properties of piperidin-3-yl-indoles that possess dopaminergic stimulating and antianoxic capabilities, supported by various alkyl and aralkyl selections. Another notable patent involves "Dopaminergic stimulating and antianoxic 4-substituted 2H-indole-2-ones," where the innovative 2H-indole-2-ones exhibit similar extraordinary properties with a focus on their preparation and therapeutic applications.

Career Highlights

Throughout his career, Claude Dumont has demonstrated a commitment to advancing pharmacological sciences. His work at Roussel Uclaf, a prominent pharmaceutical company, has positioned him at the forefront of drug innovation. His extensive research has led to the creation of numerous compounds that show promise in addressing various medical conditions through dopaminergic pathways.

Collaborations

Dumont's success is augmented by collaborations with esteemed colleagues in the industry. Notable coworkers, such as Lucien Nedelec and Jacques Guillaume, have contributed to a dynamic work environment that fosters creativity and innovation. Together, they have pushed the boundaries of pharmaceutical research, leading to breakthroughs in dopaminergic therapies.

Conclusion

In summary, Claude Dumont's work exemplifies the critical role of inventors in the development of life-enhancing pharmaceuticals. His profound contributions in the form of patents targeted at dopaminergic systems reflect his dedication to improving health outcomes. With a strong foundation in collaboration and innovation, Dumont continues to influence the field and inspire future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…